Archives

Format: 2014-09-02
Format: 2014-09-02
06/18/2014
Press Release
Today Ranking Member Henry A. Waxman sent a letter to Oversight and Government Reform Committee Chairman Darrell Issa and Ranking Member Elijah Cummings in advance of their hearing tomorrow on management challenges facing the U.S. Chemical Safety and Hazard Investigation Board (CSB). 
06/18/2014
Press Release
Today Ranking Member Henry A. Waxman sent a letter to Chairman Fred Upton regarding the release of a new HHS report that demonstrates the significant savings millions of Americans are enjoying as a result of the Affordable Care Act.  It contradicts an analysis released by Chairman Upton, which asserts premiums would rise dramatically.  The new report shows that in fact, because of the...
06/16/2014
Press Release
Today Ranking Member Henry A. Waxman released the following statement on the abduction last week of three Israeli teenagers:
06/16/2014
Press Release
Today Chairman Fred Upton and Ranking Member Henry A. Waxman wrote a letter to Margaret Hamburg, Commissioner of the U.S. Food and Drug Administration (FDA), commending the agency for reclassifying sunlamps as class II devices which require labeling that strongly urges use only by persons 18 and over.
06/12/2014
Hearing
The Subcommittee on Health held a hearing on Thursday, June 12, 2014, at 10:00 a.m. in 2123 Rayburn House Office Building.  The hearing was titled “The President’s Health Care Law Does Not Equal Health Care Access.”
06/11/2014
Hearing
The Subcommittee on Communications and Technology held a hearing on Wednesday, June 11, 2014, at 10:30 a.m. in 2123 Rayburn House Office Building.  The hearing was titled “Media Ownership in the 21st Century.”
06/11/2014
Hearing
The Subcommittee on Health held a hearing on Wednesday, June 11, 2014, at 10:00 a.m. in 2322 Rayburn House Office Building.  The hearing was titled “21st Century Cures: Examining the Role of Incentives in Advancing Treatments and Cures for Patients.”  
06/10/2014
Bill
On March 26, 2014, Rep. Joe Pitts (R-PA) and Rep. Frank Pallone (D-NJ) introduced H.R. 4299, the Improving Regulatory Transparency for New Medical Therapies Act.  H.R. 4299 requires the Drug Enforcement Administration (DEA) to place a drug or substance into the schedule recommended by the Food and Drug Administration (FDA) within 45 days of receiving the FDA recommendation.  It also...
06/10/2014
Bill
The Clean Air Act requires major new or expanding sources of air pollution to obtain permits with pollution limits before the facilities start construction.  These preconstruction permits ensure that a new or expanded facility will not increase local air pollution to levels that violate national ambient air quality standards (NAAQS), which the Environmental Protection Agency (EPA) sets for...
06/10/2014
Press Release
Today Ranking Member Henry A. Waxman and Oversight and Investigations Subcommittee Ranking Member Diana DeGette sent a letter to Chairmen Fred Upton and Tim Murphy requesting a hearing on recent findings from the U.S. Chemical Safety and Hazard Investigation Board (CSB).  The release of these new findings explain why the blowout preventer (BOP) in use on the BP Deepwater Horizon oil rig...